SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Fulcrum Therapeutics, Inc.
@FULC_InsiderForm 4 Filing: TANG KEVIN Buys $594,675.16 of $FULC
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Fulcrum Therapeutics, Inc.
Ticker: $FULC
Transaction Value
$594,675.16
Price/Share: $3.55
transaction date
2026-07-16
Shares: 167,616
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, TANG KEVIN, holds the title of 10% Owner at Fulcrum Therapeutics, Inc..
On 2026-07-16, the insider transacted 167,616 shares.The shares were transacted at a weighted average price of $3.55 per share, resulting in a total market-relevant value of $594,675.16.
Executive Summary Summary
TANG KEVIN (10% Owner) bought $595K of $FULC
Post-Transaction Position: 7,030,000 shares
SEC Accession No: 0001178579-26-000016 (CIK: 1178579)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.